- Home
- / Anpac Bio-Medical Science
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Anpac Bio-Medical Science financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$3.8
2023-07-21
Market Capitalization
$27 M
2023-07-21
Revenue
¥12 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 10.3M | 10.8M | 20.5M | 18.0M | 12.0M |
| Cost of goods sold | 2.5M | 3.4M | 4.5M | 1.8M | 3.7M |
| Gross profit | 8.3M | 7.8M | 16.0M | 16.2M | 8.3M |
| Gross profit margin, % | 72.2% | 77.9% | 89.9% | 69.2% | |
| Operating expense total | 48.8M | 94.3M | 106.0M | 118.3M | 87.8M |
| Depreciation and amortization | 3.1M | 2.7M | 3.1M | 10.0M | 25.4M |
| EBITDA | (40.5M) | (86.2M) | (90.0M) | (102.0M) | (79.3M) |
| EBITDA margin, % | -795.1% | -439.0% | -567.1% | -658.2% | |
| EBIT | (38.4M) | (96.0M) | (77.4M) | (116.8M) | (104.6M) |
| EBIT margin, % | -885.3% | -377.5% | -649.4% | -868.2% | |
| Interest expense | 925.0K | 2.6M | 1.1M | 4.3M | 373.0K |
| Pre tax profit | (42.5M) | (101.8M) | (80.7M) | (121.3M) | (105.7M) |
| Income tax expense | (199.0K) | (218.0K) | (88.0K) | (1.2M) | (2.1M) |
| Net Income | (42.3M) | (101.6M) | (80.6M) | (120.1M) | (103.6M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |